Targeting the USP13-ACLY axis in tumor endothelial cells: Ginsenoside Rd suppresses pathological angiogenesis through metabolic-epigenetic reprogramming.
Journal: Acta pharmaceutica Sinica. B
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Li H, Deng H, Liu J, et al. (2026). "Targeting the USP13-ACLY axis in tumor endothelial cells: Ginsenoside Rd suppresses pathological angiogenesis through metabolic-epigenetic reprogramming.". Acta pharmaceutica Sinica. B. https://doi.org/10.1016/j.apsb.2026.09.002